Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

612 Articles

Chris Lange | Apr 12, 2016 at 9:50 AM EDT

Short Sellers Become More Selective in Major Pharma

The March 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Lee Jackson | Apr 4, 2016 at 8:35 AM EDT

4 Jefferies Franchise Picks With Big Dividends Are Solid Q2 Buys

Now all investor eyes turn to first-quarter earnings results. With interest rates still very low, investors looking to add capital…

Lee Jackson | Mar 30, 2016 at 11:05 AM EDT

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

Long-term growth investors looking for a degree of safety and value should consider some of these outstanding companies. While the…

Chris Lange | Mar 15, 2016 at 9:25 AM EDT

Jefferies Top Drug Stocks for the Rest of 2016

For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made…

Chris Lange | Mar 10, 2016 at 8:40 AM EST

Major Pharma Short Interest Takes a Small Step Back

The February 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Lee Jackson | Mar 9, 2016 at 10:10 AM EST

Large Cap Blue Chips Dominate Jefferies Top Value Stocks to Buy

In a recent research report, Jefferiesfocused on some large cap stocks that are still trading way below their 52-week highs.

Jon C. Ogg | Mar 7, 2016 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: Enbridge, Micron, Sun Life, Starbucks, Stratasys, Wynn and Many More

The top analyst upgrades, downgrades and initiations seen from Monday, March 7, include Enbridge, Micron Technology, Sun Life Financial, Starbucks,…

Jon C. Ogg | Feb 26, 2016 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: American Water, Autodesk, Kraft Heinz, Palo Alto, Toyota, Vipshop and More

The top analyst upgrades, downgrades and initiations seen from Friday, February 26, include American Water Works, Autodesk, Kraft Heinz, Palo…

Chris Lange | Feb 25, 2016 at 8:10 AM EST

Short Sellers Increase Bets in Major Pharma

The February 12 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Lee Jackson | Feb 24, 2016 at 9:50 AM EST

Top Hedge Funds Love These 5 Big Blue-Chip Dividend-Paying Stocks

These stocks make good sense for long-term patient investors that have a growth and income total return bias in their…

Jon C. Ogg | Feb 23, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Annaly Capital, Barrick, Cheniere, Fitbit, Dean Foods, Groupon, SolarCity, Twitter, US Steel and More

The top analyst upgrades, downgrades and initiations seen on Tuesday, February 23, include Annaly Capital Management, Barrick Gold, Cheniere Energy,…

Lee Jackson | Feb 22, 2016 at 11:40 AM EST

Big Dividend Pharmaceutical Stock Now Jefferies Top Global Sector Pick

In a new research report, Jefferies shuffles some of the pharmaceutical stocks in its coverage universe and a beaten-down dividend…

Jon C. Ogg | Feb 22, 2016 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Deere, Expedia, HP Enterprise, JPMorgan, Phillips 66 and Many More

The top analyst upgrades, downgrades and initiations seen on Monday, February 22, include AbbVie, Deere, Expedia, Hewlett Packard Enterprise, JPMorgan…

Lee Jackson | Feb 19, 2016 at 8:20 AM EST

4 Blue Chip Stocks With Dividends at Least 4% and Big Upside Potential

For worried investors that need an income stream, all these top stocks make good sense for growth and income portfolios.

Lee Jackson | Feb 16, 2016 at 8:25 AM EST

Jefferies Has 4 Franchise Pick Dividend Stocks at Rock-Bottom Prices

One thing that the recent sell-off has accomplished is to take top companies residing in the Jefferies Franchise Picks list…

1 … 31 32 33 34 35 … 41

AbbVie : ABBV

All AbbVie Articles

Short Sellers Become More Selective in Major Pharma

4 Jefferies Franchise Picks With Big Dividends Are Solid Q2 Buys

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

Jefferies Top Drug Stocks for the Rest of 2016

Major Pharma Short Interest Takes a Small Step Back

Large Cap Blue Chips Dominate Jefferies Top Value Stocks to Buy

Top Analyst Upgrades and Downgrades: Enbridge, Micron, Sun Life, Starbucks, Stratasys, Wynn and Many More

Top Analyst Upgrades and Downgrades: American Water, Autodesk, Kraft Heinz, Palo Alto, Toyota, Vipshop and More

Short Sellers Increase Bets in Major Pharma

Top Hedge Funds Love These 5 Big Blue-Chip Dividend-Paying Stocks

Top Analyst Upgrades and Downgrades: Annaly Capital, Barrick, Cheniere, Fitbit, Dean Foods, Groupon, SolarCity, Twitter, US Steel and More

Big Dividend Pharmaceutical Stock Now Jefferies Top Global Sector Pick

Top Analyst Upgrades and Downgrades: AbbVie, Deere, Expedia, HP Enterprise, JPMorgan, Phillips 66 and Many More

4 Blue Chip Stocks With Dividends at Least 4% and Big Upside Potential

Jefferies Has 4 Franchise Pick Dividend Stocks at Rock-Bottom Prices

75-Year-Old With $1.3M Faces $58,000 RMD That Drags 85% of His Social Security Into Tax

A $10,000 Investment in Google When Sundar Pichai Took Over Is Worth This Much Now

If You’d Invested $10,000 In Gold When The Iran Conflict Started, Here’s How Much You’d Have Now

75-Year-Old With $1.3M Faces $58,000 RMD That Drags 85% of His Social Security Into Tax

The Real Risk in Retirement Isn't Running Out of Money. It's Losing Your Purchasing Power.

75-Year-Old With $1.3M Faces $58,000 RMD That Drags 85% of His Social Security Into Tax

A $10,000 Investment in Google When Sundar Pichai Took Over Is Worth This Much Now

AbbVie : ABBV

All AbbVie Articles

Short Sellers Become More Selective in Major Pharma

4 Jefferies Franchise Picks With Big Dividends Are Solid Q2 Buys

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

Jefferies Top Drug Stocks for the Rest of 2016

Major Pharma Short Interest Takes a Small Step Back

Large Cap Blue Chips Dominate Jefferies Top Value Stocks to Buy

Top Analyst Upgrades and Downgrades: Enbridge, Micron, Sun Life, Starbucks, Stratasys, Wynn and Many More

Top Analyst Upgrades and Downgrades: American Water, Autodesk, Kraft Heinz, Palo Alto, Toyota, Vipshop and More

Short Sellers Increase Bets in Major Pharma

Top Hedge Funds Love These 5 Big Blue-Chip Dividend-Paying Stocks

Top Analyst Upgrades and Downgrades: Annaly Capital, Barrick, Cheniere, Fitbit, Dean Foods, Groupon, SolarCity, Twitter, US Steel and More

Big Dividend Pharmaceutical Stock Now Jefferies Top Global Sector Pick

Top Analyst Upgrades and Downgrades: AbbVie, Deere, Expedia, HP Enterprise, JPMorgan, Phillips 66 and Many More

4 Blue Chip Stocks With Dividends at Least 4% and Big Upside Potential

Jefferies Has 4 Franchise Pick Dividend Stocks at Rock-Bottom Prices

75-Year-Old With $1.3M Faces $58,000 RMD That Drags 85% of His Social Security Into Tax

A $10,000 Investment in Google When Sundar Pichai Took Over Is Worth This Much Now

If You’d Invested $10,000 In Gold When The Iran Conflict Started, Here’s How Much You’d Have Now

Featured Reads

75-Year-Old With $1.3M Faces $58,000 RMD That Drags 85% of His Social Security Into Tax

The Real Risk in Retirement Isn't Running Out of Money. It's Losing Your Purchasing Power.